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Colonoscopy screening reduces colorectal cancer (CRC) incid-
ence and mortality. CRC screening is recommended at age 50 for
average-risk people. Screening of first-degree relatives of CRC pa-
tients is recommended to begin at age 40 or 10 years before the
age at diagnosis of the youngest relative diagnosed with CRC.
CRC incidence has increased recently among younger Americans
while it has declined among older Americans. The objective of
this study was to determine whether first-degree relatives of CRC
patients are being screened according to recommended guidelines.
Methods
We studied colonoscopy screening rates among the US population
reporting a CRC family history using 2005 and 2010 National
Health Interview Survey data.
Results
Of 26,064 study-eligible respondents, 2,470 reported a CRC fam-
ily history; of those with a family history, 45.6% had a colono-
scopy (25.2% in 2005 and 65.8% 2010). The colonoscopy rate
among first-degree relatives aged 40 to 49 in 2010 (38.3%) was
about half that of first-degree relatives aged 50 or older (69.7%).
First-degree relatives were nearly twice as likely as nonfirst-de-
gree relatives to have a colonoscopy (adjusted odds ratio [AOR],
1.7; 95% confidence interval, 1.5–1.9), but those aged 40 to 49
were less likely to have a colonoscopy than those in older age
groups (AOR, 2.6 for age 50–64; AOR, 3.6 for age ≥65). Interac-
tions with age, insurance, and race/ethnicity were not significant.
Having health insurance tripled the likelihood of screening.
Conclusion
Despite a 5-fold increase in colonoscopy screening rates since
2005, rates among first-degree relatives younger than the conven-
tional screening age have lagged. Screening promotion targeted to
this group may halt the recent rising trend of CRC among young-
er Americans.
Introduction
Colorectal  cancer  (CRC)  is  the  second  leading  cancer  in  the
United States; 132,700 new cases and 49,700 deaths are expected
in 2015 (1–3). The 4.3% annual decline in incidence among adults
aged 50 or older is marred by the concurrent 1.8% annual increase
among adults younger than 50; an increase in CRC incidence of
28% to 46% is anticipated for this younger age group by 2030
(1,3). Younger CRC patients typically receive a diagnosis of more
advanced disease and have poorer survival rates than older CRC
patients, and they account for 6.5% of total CRC deaths (2,4).
About 30% of CRC patients report a family history of CRC: of
those, 5% have one of the well-characterized inherited syndromes
(eg, Lynch syndrome, familial adenomatous polyposis), and the
remaining 25% are first-degree relatives of sporadic (nonheredit-
ary) CRC patients. A first-degree relative is a biological parent,
sibling, or child of a CRC patient (5–7).  First-degree relatives
have 2 to 3 times the risk of developing advanced adenomas and
cancer than the general population. The risk increases as the relat-
ive’s age at diagnosis decreases and the number of relatives with
CRC increases (8,9). About 23% of CRC patients younger than 45
years report a family history of CRC (10). Timely screening of
first-degree relatives is therefore an important tool in decreasing
rates of CRC.
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Because colonoscopy allows for the removal of benign polyps that
cause 75% to 80% of CRCs, colonoscopy screening can reduce
CRC incidence by 83% and CRC mortality by 89% (11–14). The
American College of Gastroenterology recommends first-degree
relatives of CRC patients who received their cancer diagnosis be-
fore age 60 to begin colonoscopy screening at age 40 (13). The re-
cent increase in CRC incidence among younger adults calls for
greater attention to younger first-degree relatives (3,4). Studies on
screening rates among first-degree relatives are dated, are limited
to those aged 50 or older, or are single-center studies (15,16). Sys-
tematic reviews found low rates of colonoscopy screening among
first-degree relatives (31%–40%) even though most guidelines
emphasize the importance of colonoscopy screening for this high-
er-risk group (16).  We conducted a population-based study of
CRC screening among first-degree relatives younger (aged 40–49)
than the conventional screening age of 50.
Methods
Study population
Pooled data from the 2005 and 2010 National Health Interview
Survey (NHIS) were used. The NHIS is an annual, cross-sectional,
nationally representative household survey that collects data on
CRC every 5 years through the section “Family History and Can-
cer  Screening.”  The  questions  on  cancer  family  history  (Ap-
pendix) ask whether the respondent’s biological parent, sibling, or
child ever had cancer and ask about the cancer type. The ques-
tions on CRC screening type and timing of the most recent screen-
ing test are consistent with the US Preventive Services Task Force
(USPSTF)  screening  recommendations  (12,13,17).  Our  study
sample consisted of all screening-eligible respondents in the 2 sur-
veys (Figure): all respondents aged 50 or older and all respond-
ents aged 40 to 49 who reported a family history of CRC. Of the
36,575 respondents  aged 40 or  older  in  the  2  surveys,  we ex-
cluded 10,511 respondents aged 40 to 49 who either reported not
having a CRC family history (n = 3,517) or did not respond to the
question (n = 6,994). Of 26,064 CRC screening–eligible respond-
ents, 2,470 were first-degree relatives of CRC patients and 10,454
were nonfirst-degree relatives; we were unable to determine the
family history of 13,140 respondents (aged 50 or older who did
not respond to the family history question).
Figure.  Study  sample  selected  from respondents  to  the  National  Health
Interview Surveys, 2005 and 2010. Abbreviation: CRC, colorectal cancer.
 
Measures
Because colonoscopy is the most effective screening tool to pre-
vent CRC and may be particularly important for first-degree relat-
ives (11,13), we analyzed colonoscopy screening and any CRC
screening. Per USPSTF recommendations, CRC screening com-
pletion was defined as the following: colonoscopy in the previous
10 years, a fecal blood test (FOBT or FIT) in the past year, sig-
moidoscopy in the previous 5 years,  or computed tomography
(CT) colonography in the previous 5 years (12,13). Our key de-
pendent variables of interest were colonoscopy completion (yes or
no) and any CRC screening (yes or no). The key independent vari-
ables were family history of CRC (first-degree relative, nonfirst-
degree relative,  or no response to the question),  age (40–49 y,
50–64 y, or ≥65 y), race/ethnicity (white, African American, His-
panic, or other) and health insurance (private; public, including
Medicaid  and  Medicare;  or  uninsured).  Survey  year  (2005  or
2010) was used to examine changes over time. We controlled for
marital status and education level (18).
Statistical analysis
We used χ2 tests to examine differences between subgroups separ-
ately for 2005 and 2010. Weighted logistic regression analyses of
the pooled data were used to model the likelihood of colonoscopy
screening (vs no colonoscopy) and any CRC screening (vs no
screening).  We studied associations  with  CRC family  history,
health insurance, age, sex, and race/ethnicity, controlling for mar-
ital status and education. Interactions of family history with age,
sex, race/ethnicity, and health insurance were tested. We conduc-
ted weighted regression analyses to account for the stratification
hierarchy and nonresponse bias and used a 2-sided test of signific-
ance at the .01 level as recommended by the National Center for
Health Statistics. SAS v9.3 (SAS Institute Inc) was used.
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Results
The pooled sample consisted of 26,064 respondents (13,731 in
2005 and 12,333 in 2010). The colonoscopy rate was 49.1% in
2010, about 3 times the rate of 16.5% in 2005. Among first-de-
gree relatives, 65.8% completed colonoscopy in 2010 and 25.2%
in 2005, compared with 57.0% in 2010 and 19.0% in 2005 among
non-first-degree relatives and 38.5% in 2010 and 12.7% in 2005
among nonrespondents (Table 1). Use of flexible sigmoidoscopy,
FOBT,  and  CT  colonography  was  negligible.  Although  the
colonoscopy rate tripled from 2005 to 2010 among first-degree re-
latives aged 40 to 49 (Table 2), the rate among this younger group
in 2010 (38.3%) was about half the rate (69.7%) among first-de-
gree relatives aged 50 years or older (69.1% among adults aged
50–64 and 70.3% among those aged ≥65).
The  likelihood  of  having  a  colonoscopy  versus  not  having  a
colonoscopy was 5 times higher in 2010 than in 2005 after adjust-
ment for age, sex, race/ethnicity, health insurance, and other cov-
ariates (adjusted odds ratio [AOR], 5.4; 95% confidence interval
[CI], 5.0–5.8) (Table 3). First-degree relatives were 70% more
likely than nonfirst-degree relatives to have a colonoscopy (AOR,
1.7; 95% CI, 1.5–1.9). Nonrespondents were about half as likely
as nonfirst-degree relatives to have a colonoscopy. The likelihood
of colonoscopy among first-degree relatives aged 40 to 49 was
about one-third that of the older age groups (AOR, 2.6 for those
aged 50–64; AOR, 3.6 for those aged ≥65). Respondents who had
private or public health insurance were 3 times as likely as those
who were not insured to have a colonoscopy (AOR, 3.3 for private
insurance; AOR, 3.4 for public insurance). African Americans and
whites were equally likely to have a colonoscopy. Interactions of
first-degree relative status with age, health insurance, and race/eth-
nicity were not significant. The results did not change when data
on all screening tests were combined.
Discussion
The key finding of this study is that first-degree relatives younger
than the conventional screening age of 50 were less likely than
adults aged 50 or older to have had a colonoscopy. Although stud-
ies document screening rates among first-degree relatives of inher-
ited CRC syndromes, few studies are available on first-degree rel-
atives of sporadic CRC patients, even though they are the largest
higher-risk subgroup in the population. Our study shows the need
for increasing screening rates in this subgroup, particularly first-
degree relatives younger than 50 because of the recent increase in
CRC among American adults in this age group.
The low colonoscopy rate among younger first-degree relatives
(40%) observed in our study should be viewed in light of the mul-
tifold  increase  in  colonoscopy  rates  between  2005  and  2010
(69.7%) among adults  in  the  widely  publicized screening age
group. Studies of first-degree relatives of sporadic CRC patients
either focused on first-degree relatives aged 50 or older or used
mixed-age samples without distinguishing younger first-degree re-
latives. Our other study findings are also consistent with those of
earlier studies (19-22). Among the population aged 50 or older,
colonoscopy rates were higher among first-degree relatives than
among nonfirst-degree relatives. A recent study using NHIS 2010
data on adults  aged 50 or  older  reported colonoscopy rates  of
72.3% among first-degree relatives and 53.5% among nonfirst-de-
gree relatives, similar to our finding (19). A study based on NHIS
2000 data on adults aged 41 to 75 reported colonoscopy rates of
27.8% among first-degree relatives and 7.7% among nonfirst-de-
gree relatives (20). Only 1 population-based study using NHIS
2000 data on younger first-degree relatives is available: although it
did not distinguish among screening types, it reported that 15.8%
of men and 8.9% of women aged 40 to 49 had a CRC screening
test (22). One meta-analysis of 7 studies reported a pooled colono-
scopy rate  of  40% among all  first-degree relatives aged 40 or
older; no study in the analysis included recent data (23).
Our findings are also consistent with the findings of single-center
studies. A practice-based patient survey in 2004 showed a colono-
scopy rate of 29.6% among first-degree relatives younger than 50
and a rate of 76% among first-degree relatives aged 50 or older.
Only 39% of first-degree relatives younger than 50 had ever been
asked by their physician about a CRC family history, and almost
half (46%) believed that screening should begin at age 50 (24).
Another study reported that the lack of physician recommendation
was the single most important reason that first-degree relatives
younger than 50 years had not undergone colonoscopy screening
(25). Lack of awareness among first-degree relatives of the need
for early screening and lack of physician recommendation appear
to be major reasons for the low screening rates among first-degree
relatives younger than 50. Screening education may have a great-
er effect among first-degree relatives because of their personal ex-
posure to CRC through family members.
Consistent with prior studies, we found that having health insur-
ance  increased  the  likelihood  of  colonoscopy  screening
(19,23,26,27). Colonoscopy screening rates among Medicare en-
rollees  increased after  2001,  when colonoscopy coverage was
launched, from a mean quarterly rate of 285 per 100,000 benefi-
ciaries during 1992–1997 to 1,919 per 100,000 beneficiaries dur-
ing 2001–2002 (28).  The Affordable Care Act (ACA) now re-
quires  first-dollar  coverage  of  preventive  services,  including
colonoscopy, a provision that was not in force during the NHIS
2010 survey. Screening promotion among younger first-degree re-
latives in the ACA environment has a better chance of increasing
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screening rates than in the pre-ACA environment, although we
would expect some attenuation of effect because of the general
tendency of younger adults not to avail themselves of preventive
health services and because grandfathered health plans are not re-
quired to conform to ACA provisions (4).
Our study has several limitations. One is response-rate bias: half
of the sample did not answer the family history question, and they
were systematically different from the half that did answer the
question: they were half as likely as nonfirst-degree relatives to
have undergone colonoscopy screening. Another limitation is that
data were self-reported (ie, data were not extracted from medical
records), which may have resulted in overestimation of screening
rates (19,29). Finally, imbalanced cell sizes of the family history
variable (2,470 vs 10,454) may limit the accuracy of odds ratio es-
timates.
Despite these limitations, our study is important in highlighting
that first-degree relatives aged 40 to 49 of CRC patients are an un-
dertargeted (and potentially rewarding) group for focused promo-
tion of CRC prevention. Screening promotion should target both
physicians and patients: alerting primary care physicians to en-
gage younger patients in learning about a potential CRC family
history and educating CRC patients to alert their first-degree relat-
ives to initiate screening discussions with their physicians. Our re-
cent report of an 83% reduction in CRC incidence and an 89% re-
duction in CRC mortality after screening colonoscopies should
boost enthusiasm for colonoscopy screening among both patients
and physicians (11). Coupled with the ACA provisions requiring
coverage of screening procedures, such efforts can help arrest the
increase in CRC among Americans younger than 50 years (1,10).
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Tables
Table 1. Colorectal Cancer (CRC) Screening–Eligible Adult Respondents Aged 40 Years or Older, Classified By CRC Family
Historya, National Health Interview Survey 2005 and 2010 (n = 26,064)
Characteristic


















Male 37.1 39.4 45.5 37.5 40.4 45.4
Female 62.9 60.6 54.5 62.5 59.6 54.6
Ageb, y
40–49 18.5 0 0 17.7 0 0
50–64 38.1 54.6 54.5 41.3 54.6 55.3
≥65 43.4 45.4 45.5 41.0 45.4 44.7
Race/ethnicityb
White 85.5 87.0 74.7 83.1 83.6 71.1
African American 7.9 7.1 12.9 9.0 8.7 13.4
Hispanic 4.1 4.2 8.0 4.9 5.5 10.2
Other 2.4 1.8 4.5 2.9 2.2 5.3
Insuranceb
Private 44.9 43.8 41.9 46.3 41.2 40.0
Public 48.7 49.8 49.7 46.0 51.5 49.9
Uninsured 6.4 6.3 8.0 7.4 7.1 9.8
CRC screening typeb
Colonoscopy 25.2 19.0 12.7 65.8 57.0 38.5
Sigmoidoscopy 1.4 2.7 1.3 0.4 1.2 0.9
FOBT 0.5 0.5 0 1.7 3.2 2.6
CT colonography NA NA NA 0.1 0 0.1
No screening 73.0 77.9 85.7 32.1 38.6 57.9
Abbreviations: CT, computed tomography; FOBT, fecal occult blood test; NA, not asked in the 2005 survey.
a Family history defined as self-reporting as a first-degree relative (biological parent, sibling, or child) of a CRC patient.
b P < .001 for all tests of difference between family history, no family history, and no response groups.
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Table 2. Colorectal Cancer (CRC) Screening Status by Age Group and CRC Family Historya, National Health Interview Sur-













Have a family history (n = 2,470)
40–49 y 251/196 12.7 1.6 85.7 38.3 3.1 58.7
50–64 y 524/470 21.4 1.3 77.3 69.1 1.7 29.1
≥65 y 571/458 32.0 2.5 65.5 70.3 2.2 27.5
No family history (n = 10,454)
50–64 y 2,964/2,805 14.5 3.1 82.4 52.6 4.4 43.0
≥65 y 2,385/2,300 23.4 3.2 73.4 61.2 4.7 34.1
No response (n = 13,140)
50–64 y 3,914/3,412 9.2 1.4 89.3 34.4 3.8 61.8
≥65 y 3,122/2,692 15.3 1.8 82.8 40.9 3.1 56.0
Abbreviations: CT–C, computed tomography colonography; FOBT, fecal occult blood test; FS, flexible sigmoidoscopy.
a Family history defined as self-reporting as a first-degree relative (biological parent, sibling, or child) of a CRC patient.
b Total respondents in the category in 2005 and 2010, respectively.
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Table 3. Adjusted Likelihood of Colonoscopy Among US Adults Aged 40 or Older With a Family History of Colorectal Can-
cer (CRC)a, National Health Interview Survey 2005 and 2010 (n = 26,064)b













African American 1.0 (0.9–1.1)
Hispanic 0.8 (0.7–1.0)
Other 0.7 (0.6–0.8)
Family history of CRC
Have a family history 1.7 (1.5–1.9)
No family history 1.0 [Reference]





a Family history defined as self-reporting as a first-degree relative (biological parent, sibling, or child) of a CRC patient.
b Additionally adjusted for marital status and education. Income was not significant and was excluded from the model.
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Appendix. National Health Interview Survey (NHIS) Questions on Colorectal
Cancer Family History and Screening Tests, 2005 and 2010
The survey questions on colorectal cancer family history and screening are located in the sample adults cancer file. Questions
are similar in both years. The original questions used to create the study variables are the following:
Question Answer
What kind of cancer did your father have . . . colon?
1, Mentioned; 2, Not mentioned; 7, Refused; 8, Not
ascertained; 9, Don’t know
What kind of cancer did your father have . . . rectum?
What kind of cancer did your mother have . . . colon?
What kind of cancer did your mother have . . . rectum?
What kind of cancer did your (brother/brothers) have . . . colon?
What kind of cancer did your (brother/brothers) have . . . rectum?
What kind of cancer did your (brother/brothers) have . . . rectum?
What kind of cancer did your (sister/sisters) have . . . colon?
What kind of cancer did your (sister/sisters) have . . . rectum?
What kind of cancer did your (son/sons) have . . . colon?
What kind of cancer did your (son/sons) have . . . rectum?
What kind of cancer did your (daughter/daughters) have . . . colon?
What kind of cancer did your (daughter/daughters) have . . . rectum?
NHIS 2010
Most recent sigmoidoscopy, time categories (using 2005 method) 1, A year ago or less; 2, More than 1 year but not more
than 2 years; 3, More than 2 years but not more than 3
years; 4, More than 3 years but not more than 5 years; 5,
More than 5 years but not more than 10 years; 6, Over
10 years ago; 7, Refused; 8, Not ascertained; 9, Don't
know
Most recent home blood stool test, time categories (using 2005 method)
Most recent CT colonography or virtual colonoscopy, time categories
NHIS 2005
Was this MOST RECENT exam a sigmoidoscopy, colonoscopy, proctoscopy
or something else?
1, Sigmoidoscopy; 2, Colonoscopy; 3, Proctoscopy; 4,
Something else; 7, Refused; 8, Not ascertained; 9, Don’t
know
Most recent colorectal exam, time categories 1, A year ago or less; 2, More than 1 year but not more
than 2 years; 3, More than 2 years but not more than 3
years; 4, More than 3 years but not more than 5 years; 5,
More than 5 years but not more than 10 years; 6, Over
10 years ago; 7, Refused; 8, Not ascertained; 9, Don’t
know
Most recent office blood stool test, time categories
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